Sensitivity and Specificity of Glycated Hemoglobin As a Diagnostic Test for Diabetes and Prediabetes in Arabs
Overview
Affiliations
Context: Glycated hemoglobin (A1C) has been recommended by the American Diabetes Association for the diagnosis of diabetes and prediabetes. The diagnostic utility of A1C has not been evaluated in Arabs, a population at increased risk for developing diabetes.
Objective: Our objective was to examine the sensitivity and specificity of A1C for the diagnosis of diabetes and prediabetes in Arabs.
Design & Setting: In this cross-sectional study, glucose tolerance was classified by the American Diabetes Association diagnostic criteria specified for A1C, fasting plasma glucose, and 75-g oral glucose tolerance test.
Participants: A population-based representative sample of 482 randomly selected adult Arabs without known diabetes was studied.
Main Outcome Measures: Sensitivity, specificity, and area under the receiver operating characteristic curve of A1C diagnostic cutpoints for diabetes and prediabetes were calculated. κ Coefficients were used to test for agreement between A1C categorization and glucose-based diagnoses.
Results: A1C testing correctly identified 5% of individuals diagnosed with diabetes by oral glucose tolerance test, 13% by fasting plasma glucose, and 41% by both criteria. A1C alone identified 14% of individuals diagnosed with impaired glucose tolerance, 9% with impaired fasting glucose, and 33% with both abnormalities. Sensitivity, specificity, and area under the receiver operating characteristic curve were 19% (16-23%), 100% (99-100%), and 77% (69-85%) for diabetes A1C cutpoint and 14% (11-17%), 91% (89-94%), and 57% (52-62%) for prediabetes A1C range. A1C cutpoint of 6.2% for diabetes and 5.1% for prediabetes yielded the highest accuracy but still missed 73% of those with diabetes and 31% with prediabetes. Agreement between A1C and diabetes (κ = 0.2835) or prediabetes (κ = 0.0530) was low.
Conclusions: A1C-based criteria yield a high proportion of false-negative tests for diabetes and prediabetes in Arabs.
Summary: Racial/ethnic differences in A1C performance for diagnosis and prediction of diabetes exist. This paper examines its utility against glucose measurements in an at-risk Arab population.
Barbu E, Popescu M, Popescu A, Balanescu S Int J Mol Sci. 2021; 22(13).
PMID: 34202289 PMC: 8268766. DOI: 10.3390/ijms22136864.
Hobabagabo A, Osei-Tutu N, Hormenu T, Shoup E, DuBose C, Mabundo L Diabetes Care. 2020; 43(10):2607-2613.
PMID: 32801129 PMC: 7510044. DOI: 10.2337/dc20-1119.
Phuphuakrat A, Nimitphong H, Reutrakul S, Sungkanuparph S AIDS Res Ther. 2020; 17(1):25.
PMID: 32448349 PMC: 7247133. DOI: 10.1186/s12981-020-00284-1.
Iskandar S, Migahid A, Kamal D, Megahed O, DeFronzo R, Zirie M BMC Endocr Disord. 2019; 19(1):87.
PMID: 31438915 PMC: 6704621. DOI: 10.1186/s12902-019-0412-1.
Anderson P, Grills N, Singh R, Singh R, Evans R, Sengupta P BMC Public Health. 2019; 19(1):817.
PMID: 31234815 PMC: 6591826. DOI: 10.1186/s12889-019-7184-4.